P3487Pre-ischemic succinate dehydrogenase inhibition is protective against ischemia-reperfusion injury in rat and human myocardium with and without diabetes mellitus
Nichlas Riise Jespersen(Aarhus University), Hans Erik Boetker(Aarhus University Hospital), Thomas Ravn Lassen(Aarhus University Hospital), N. B. Stoettrup(Aarhus University Hospital), Jacob Johnsen(Aarhus University Hospital), Steen Larsen(University of Copenhagen), Pernille Tilma Tonnesen(Aarhus University), Hans‐Henrik Kimose(Aarhus University Hospital), Marie Vognstoft Hjortbak(Aarhus University Hospital)
Cited by 0
Related Papers
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|526
Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles
|Basic Research in Cardiology|2021|52
Clinical translation of myocardial conditioning
|American Journal of Physiology-Heart and Circulatory Physiology|2018|39
Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus
|Scientific Reports|2020|39
Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
|Scientific Reports|2021|37